Pharma Stocks Gain Momentum: Lupin, Aurobindo Pharma, Medanta & Apollo In Focus

Pharma stocks are picking up pace, with the sector continuing to show a strong overall technical setup despite the possibility of short-term profit booking. Gaurav Bissa, Senior Vice President, Equity Advisor, InCred Capital, explains why sector rotation could lead to some time and price correction in stocks that have already rallied sharply. He highlights Lupin and Aurobindo Pharma while cautioning investors to focus on favourable risk-reward opportunities. The discussion also covers hospital stocks such as Medanta and Apollo Hospitals, along with diagnostic companies, where the broader technical structure remains positive despite recent corrections.